Clinical Trial

Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study

Study acronym: AI-PRA
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to provide initial proof-of-concept validation data of an artificial intelligence-based model to estimate individual Parkinson's disease risk using demographic, clinical, genetic information and digital biomarker data collected via a smartwatch and a mobile application.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-07-15.
Trial Details
NCT Number NCT07706829
Lead Sponsor Queen Mary University of London
Collaborators: Hospital Ruber Internacional, University Hospital, Toulouse, Aristotle University Of Thessaloniki
Conditions Parkinson Disease (PD), REM Sleep Behavior Disorder (iRBD), Neurogenic Orthostatic Hypotension, Hyposmia
Enrollment 60 participants
Start Date 2026-07-01
Primary Completion 2027-09-30 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-20